| Literature DB >> 27330640 |
Warren Chang, Andrew Scarano, Laurence Berg.
Abstract
A previously healthy 16-year-old male patient came to the emergency department with a six-week history of left posterior hip pain following a head-on ATV collision. After failing conservative therapy, he was found to have weakness and atrophy of the left lower extremity on exam. MRI demonstrated an epidural mass that was hyperintense on T1 and hypointense on T2. Biopsy of the mass revealed a melanocytic lesion; further lesions were identified in the lungs, which biopsy proved to be malignant melanoma. Dermoscopy of the entire body, anoscopy, and retinal exam were negative for melanoma; a whole-body PET scan did not reveal any further lesions or evidence of a primary lesion. Given the lack of a primary lesion, this was thought to be a primary leptomeningeal melanoma. Primary melanomatous tumors of the spine are rare entities, with fewer than 40 cases described in the literature. This case was unique due to the patient's very young age and the presence of metastases on presentation.Entities:
Year: 2015 PMID: 27330640 PMCID: PMC4900124 DOI: 10.2484/rcr.v8i3.857
Source DB: PubMed Journal: Radiol Case Rep ISSN: 1930-0433
Figure 116-year-old male with primary leptomeningeal melanoma. A T1-weighted image of the lumbar spine shows a hyperintense epidural mass.
Figure 216-year-old male with primary leptomeningeal melanoma. A T2-weighted image of the lumbar spine shows a hypo- to isointense epidural mass.
Figure 316-year-old male with primary leptomeningeal melanoma. A slide from the resection of the epidural lesion at the base of the spine shows a largely necrotic tumor. The better preserved cells are dyscohesive, with round pyknotic nuclei and moderately abundant eosinophilic cytoplasm. Mitoses are not seen, and the MIB-1 rate (a measure of the cellular reproductive rate) was very low. Abundant dark brown patches suggest a melanocytic neoplasm.
Figure 416-year-old male with primary leptomeningeal melanoma. Immunohistochemistry for the melanocyte-specific marker Melan-A shows the characteristic cytoplasmic staining, confirming the diagnosis of a melanocytic neoplasm.